Diabetic myopathy differs between Ins2Akita+/- and streptozotocin-induced Type 1 diabetic models.
about
Skeletal muscle as a therapeutic target for delaying type 1 diabetic complicationsNrf2 modulates contractile and metabolic properties of skeletal muscle in streptozotocin-induced diabetic atrophyMuscle-specific adaptations, impaired oxidative capacity and maintenance of contractile function characterize diet-induced obese mouse skeletal muscle.Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes.Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: a model of adolescent type 1 diabetic myopathy?A novel cellular defect in diabetes: membrane repair failure.Impaired macrophage and satellite cell infiltration occurs in a muscle-specific fashion following injury in diabetic skeletal muscle.Inhibition of plasminogen activator inhibitor-1 restores skeletal muscle regeneration in untreated type 1 diabetic mice.Overload-induced skeletal muscle hypertrophy is not impaired in STZ-diabetic ratsDiabetic Myopathy and Mechanisms of Disease.Myostatin inhibition therapy for insulin-deficient type 1 diabetesDiabetic myopathy: impact of diabetes mellitus on skeletal muscle progenitor cells.Effects of type 1 diabetes mellitus on skeletal muscle: clinical observations and physiological mechanisms.Exercise and type 1 diabetes (T1DM).Pathophysiology of Bone Fragility in Patients with Diabetes.Acute Elevated Glucose Promotes Abnormal Action Potential-Induced Ca2+ Transients in Cultured Skeletal Muscle Fibers.Diabetes and stem cell function.Xin-deficient mice display myopathy, impaired contractility, attenuated muscle repair and altered satellite cell functionality.Statin Therapy Alters Lipid Storage in Diabetic Skeletal MuscleInterval training attenuates the metabolic disturbances in type 1 diabetes rat model.Both spontaneous Ins2(+/-) and streptozotocin-induced type I diabetes cause bone loss in young mice.The Underlying Mechanisms of Diabetic Myopathy.In vivo imaging of intracellular Ca2+ after muscle contractions and direct Ca2+ injection in rat skeletal muscle in diabetes.The effects of voluntary exercise and prazosin on capillary rarefaction and metabolism in streptozotocin-induced diabetic male rats.Effects of short-term severe and long-term mild STZ-induced diabetes in urethral tissue of female rats.Voluntary physical activity and leucine correct impairments in muscle protein synthesis in partially pancreatectomised rats.Morphological changes in rat rectus abdominis muscle induced by diabetes and pregnancy.Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy.
P2860
Q26775403-150CC7B5-CE9C-41C6-B234-6DF69590E590Q28390266-8F1DA9DE-97B3-43D3-A957-C88545EE1D7AQ33508811-CA867B99-F5C0-4980-AA10-083B1CD7DF1BQ33709609-4137BC8C-F72B-46CE-9DD1-F3ADD03B5688Q33754537-607E2F2C-3DBF-40E5-B02F-9E891A36EF12Q34028243-DAFE33B4-6F6E-4E75-A3E3-4D8C93A872C7Q34948256-73D2AD4F-1A93-4ADE-B155-EE2F91AF47FEQ35063242-3F135DD1-6620-472A-9FA1-BC708CF040ACQ36004376-D5D6FEB3-36CF-44B4-83CB-B101055AD6A4Q36362817-05819A4D-C7B4-4428-A369-2CE02FE466ECQ37223399-A7F538BC-868C-4E65-9E21-6DB80038C5F7Q37405521-841D0BF0-52CB-4865-95C2-5514D7F011F5Q37791182-3AEB8959-A15A-418D-B0BC-D31B45E3809CQ38125149-9453AC0A-CEFC-4026-8CB6-CE2B4877892BQ39127683-BB25760D-D528-4137-9509-E0FD74D29398Q41403265-AFC63860-2B48-47B1-B8FE-3BDA45F9EE4EQ41443846-3E101104-FF12-4672-8F5E-85CE16881C56Q41591485-E8AFB127-6086-40DF-A151-2733B4118175Q42070460-4ABE802A-CCFA-4D72-94B9-E92DB7CC7FDBQ44260459-1BBFD2B0-742A-42C3-BB9C-FA8CD7292AFEQ46738589-3781A0AD-6722-42C4-811F-94EEDB7BF674Q47162674-23C2E248-D77F-4850-827F-0D6E8DE68706Q47943096-54D80C86-BEC7-4DEC-A149-DFEC2C176224Q48173032-85B034A9-692A-4D40-B962-E8BCFA92BB23Q50922642-F9B0003F-21A7-43F4-9C75-0EA8CC876A52Q51368489-97F915C2-83D8-4657-94E3-B05ED525134FQ52689236-C61376D7-138B-440D-ADEB-769AAF6D0FD3Q54551322-5DACE3AF-9B07-4DB8-9A9F-D295451D12B9
P2860
Diabetic myopathy differs between Ins2Akita+/- and streptozotocin-induced Type 1 diabetic models.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Diabetic myopathy differs betw ...... nduced Type 1 diabetic models.
@en
Diabetic myopathy differs betw ...... nduced Type 1 diabetic models.
@nl
type
label
Diabetic myopathy differs betw ...... nduced Type 1 diabetic models.
@en
Diabetic myopathy differs betw ...... nduced Type 1 diabetic models.
@nl
prefLabel
Diabetic myopathy differs betw ...... nduced Type 1 diabetic models.
@en
Diabetic myopathy differs betw ...... nduced Type 1 diabetic models.
@nl
P2093
P2860
P1476
Diabetic myopathy differs betw ...... nduced Type 1 diabetic models.
@en
P2093
Carly S Gordon
Enzo Cafarelli
Matthew P Krause
Michael C Riddell
S Abdullah Imam
P2860
P304
P356
10.1152/JAPPLPHYSIOL.91565.2008
P407
P577
2009-02-26T00:00:00Z